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Distribution of lymphoid nodules, aberrant crypt foci and tumours in the
colon of carcinogen-treated rats
IL Cameron, J Garza and WE Hardman
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Summary Sprague-Dawley rats were given eight weekly subcutaneous injections of 1,2-dimethylhydrazine
(DMH) or of vehicle then were sacrificed at 1, 5 or 24 weeks after the last injection of DMH. The locations of
pre-existing aggregates of lymphoid nodules (ALNs), the location and multiplicity (size) of aberrant crypt foci
(ACF), and the locations of tumours in the colon were determined. A trimodal distribution of pre-existing
ALNs along the length of the colon was significantly correlated with the timodal distribution of DMH-induced
adenocarcinomas (ACs). A unimodal peak in ACF of all sizes occurred between the sites of two distal ALNs.
Thus, the distribution ofACF at 1 or 5 weeks did not correlate with the distribution ofAC found at 24 weeks.
Of the 2640 ACF observed at 1 or at 5 weeks, none were found in the proximal 25% of the colon where ACs
eventually occurred. It was concluded that: (1) ALNs play a promotional role in AC formation; (2) the ACs
which form in the proximal quarter of the colon seldom if ever form via an ACF precursor; and (3) the
location, the number and the size of ACF observed early after DMH exposure did not correlate with the
location or predict the incidence of ACs which eventually formed in the colon.
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This report concerns the distribution of aggregates of
lymphoid nodules (ALNs), of aberrant crypt foci (ACF)
and of tumours along the length of the colon in carcinogen-
treated rats. The results of the study provide information
about the role that ALNs and ACF play in determination of
the distribution of colonic adenocarcinomas (ACs) in rats.
ALNs are normal features in the colon of rats that have
not been exposed to a colon carcinogen and are consistently
found at three distinct sites along the length of the colon of
Sprague-Dawley rats (Nauss et al., 1984; Hardman and
Cameron, 1994). Solitary lymphoid nodules are rarely
observed outside the limits of one of these three sites of
ALNs in the rat colon. This unique anatomical distribution
of lymphoid nodules in the rat allows study of the role of the
lymphoid nodules on colorectal carcinogenesis which is not
possible in species in which individual lymphoid nodules are
more uniformly distributed in the colon.
The findings from several reports (Nauss et al., 1984;
Martin et al., 1986; Shamsuddin and Hogan, 1984; Bland and
Britton, 1984) have indicated that the majority ofcarcinogen-
induced ACs in the colon of rats occur in close spatial
association with each ALN site. In addition, it has been
reported that a large proportion of these ACs originate as
microscopic, endophytic AC within the ALN (Hardman and
Cameron, 1994). Furthermore, the microscopic, endophytic
ACs found within the ALNs showed no evidence of an
adenomatous precursor, suggesting that these endophytic
ACs arose de novo (Hardman and Cameron, 1994). It was
concluded that ALNs are promotional to development of
microscopic, endophytic ACs in the rat and to development
of ACs in general.
In a recent report addressing the hypothesis that ACF are
carcinogen-induced premalignant lesions in the colon of rats
(Caderni et al., 1995), the authors examined morphological
parameters and mucin production in ACF of whole colons
from carcinogen-treated rats to assess the putative premalig-
nant potential of the ACF. The authors found no statistically
significant association between either the number of ACF or
the size of ACF and the presence of tumours in the colon.
The authors did find an association between the presence of a
tumour, the number of very large ACF (> 14 aberrant crypts
per focus) and the presence of sialomucin-producing ACF.
These reports indicate that there may be at least two
distinct pathways to carcinogen-induced AC development in
the rat colon: one a de novo pathway progressing via the
microscope, endophytic lesion associated with the ALN and
another pathway progressing via the ACF lesion. It seems
reasonable to suggest that if ACF are the main primary early
precursor lesions on the pathway to AC formation, then the
distribution of ACF along the colon would correlate with the
distribution of the ACs. To test this possibility, the
distribution of ACF of different sizes and the distribution
of tumours along the length of the colon were determined at
times after the initiation of DMH-induced colon carcinogen-
esis in rats. The distributions of ACF and of tumours were
then compared with the distribution of ALN to determine if
the location of ALN would correlate with the location of
DHM-induced tumours. Such correlations might indicate
whether the presence of ALNs or of ACF is the main
determinant of the eventual location of ACs. The location of
ALN was scored in the large intestine of saline (non-DMH)-
treated rats to be sure that lymphoid aggregates were pre-
existing structures in the colon and were not formed in
response to the DMH treatments or to the presence of a
tumour.
This study was specifically designed to test if the
distribution of DMH-induced ACF in the colon, scored
early in the carcinogenic process, is predictive of the incidence
and location of tumours which eventually occur in the colon
and to test for a putative promotional role for ALN in colon
carcinogenesis.
Materials and methods
Animals
Four- to six-week-old, male Sprague -Dawley rats were
obtained from Harlin (Houston, TX, U.S.A.). Cages had
solid plastic sides with high, wire mesh false bottoms to
minimise access to the bedding or faeces. All rats were
housed in the same well-ventilated room (20 air changes per
hour), at a temperature of 250C and automatically controlled
light/dark cycle of 14/10 h. All rats had ad libitum access to
food [the standard semipurified AIN-76 formula (American
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Institute of Nutrition, 1977)] and deionised water during the
entire experiment. This protocol was approved by the
Institutional Animal Care and Use Committee.
Experimental design
Upon receipt, the rats were randomly paired, assigned cages
and ear marked for identification. Ten days were allowed for
adjustment to their new environment. Dimethylhydrazine
(DMH) solutions [26.6 mg of 1,2-dimethylhydrazine dihy-
drochloride (99 + % pure, Aldrich, Milwaukee, WA, USA)
per ml made in 0.9% saline and 0.18% EDTA then pH
adjusted to 6.5 with sodium hydroxide [were freshly prepared
each week. Rats received subcutaneous injections of 12 mg of
DMH base per kg body weight (0.1 ml of solution 100 g-1
body weight) or of the saline/EDTA vehicle once each week
for 8 weeks. Groups of rats were killed at 1, 5 and 24 weeks
after the last of the eight weekly injections of DMH or of the
vehicle. One group of rats (injected with vehicle only) was
killed at 20 weeks of age for analysis of the distribution of
pre-existing ALNs along the length of the colon.
Tissue preparation and analyses
The rats were ether anaesthetised, then killed by decapitation
and a gross pathological examination was performed. The
colon was removed, cut open longitudinally and examined for
tumours and tumour-like lesions. The longitudinal folds in
the colon were gently stretched open and the colon was
pinned flat, serosal side down, onto corkboard. The width
and total length of each colon were measured and recorded,
then the colon was fixed in 10% neutral buffered formalin.
All tumours and suspected tumours were identified macro-
scopically and their distance from the anus was measured and
recorded. Tumours and suspected tumours were removed,
fixed in formalin and processed for histology. Four-micron-
thick step sections of the entire tumour were cut, mounted on
glass slides and stained with haematoxylin and eosin.
Microscopic examination of the histological sections was
used to classify each of these macroscopic tumours as an
adenoma or as an adenocarcinoma.
Staining and counting ofaggregates oflymphoid nodules and of
aberrant crypt foci
Tannin, leached from the corkboard onto which the colon
was pinned, differentially stained the tissue and aided
visualisation of the ALNs using transillumination and a
dissecting microscope (Figure 1). The identification of ALNs
using a dissecting microscope was confirmed using histologi-
cal sections through the ALNs. The distance from the anus to
the distal end and to the proximal end of each ALN was
measured and recorded. All distance measurements were
eventually normalised to per cent distance from the anus to
the ileum. This normalisation procedure adjusts for normal
deviations in the large bowel length between individual rats
and for shrinkage due to fixation. Only ALNs from non-
DMH-treated rats were used in the statistical assessment of
the ALN distribution because a correlation of tumour
distribution with the distribution of pre-existing ALNs was
sought to determine if ALNs had a promotional role in the
carcinogenesis process.
Methylene blue stain [0.5% in phosphate-buffered saline
(PBS), pH 7.1] was used to aid visualisation of the ACE. The
colon was removed from the cork and placed luminal side up
into a Petri dish and flooded with stain. After about 30 min,
excess stain was rinsed off with PBS. The colon was placed
into a Petri dish which had a centimetre scale marked on the
bottom, then placed under a stereomicroscope (30 x mag-
nification) and transillumination was used for scoring of
ACE. The number and size classification of ACF in each
1 cm along the length of the colon were counted and
recorded.
Statistical analysis
The SPSSX plus statistical package (Nie et al., 1983) was used
for statistical evaluations. The statistical tests used included
two-way analysis of variance (ANOVA), one-way ANOVA,
and Student-Newman-Keuls multiple range tests to
determine significant differences between group means.
Linear regression analysis was used to determine correlation
between variables.
Results
Location of ALNs along the length of the colon
ALN were present at one or more of three distinct sites in the
colon of each rat. Specifically, a total of 20 non-DMH-
treated rats were scored for distribution of ALN. All 20 rats
had a visible ALN in the distal colon (located at 19.2+0.4%
of the distance from the anus), 12 had a visible ALN in the
mid-colon (located at 53.9+ 1.7%) and 17 had a visible ALN
in the proximal colon (located at 88.3+1.5%).
Numbers and sizes ofACF in the colon ofrats killed at 1 and
at 5 weeksfollowing the eight weekly injections of DMH
No aberrant crypts were found in the colon of the rats that
had not been injected with colon carcinogen. The number of
ACF was recorded by size (number of aberrant crypts per
b
Figure 1 (a) Photomicrograph of a portion of a transilluminated aggregate of lymphoid nodules (ALN) in the descending colon of
a Sprague-Dawley rat (surface view, whole mount, tannin stain). (b) The central zone of each of the 7-8 nodules appears smooth
without crypt mouths (arrowheads point to two examples). The mouths of the colonic crypts can be observed around the edge ofthe
smooth central zone.Lymph nodules, aberrant crypts and colon cancer
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focus) and by location in the colon. The mean numbers of
ACF of each size+s.e.m. in the colon of rats killed 1 week
after the last DMH injection were: one crypt per focus,
142.8 +28.3; two crypts per focus, 56.3 +5.6; three crypts per
focus, 20.3 +4.1; four crypts per focus, 6.3+0.6; five crypts
per focus, 1.5+0.5; six crypts per focus, 0.8+0.5. The mean
numbers of ACF of each size (+ s.e.m.) in the colon of rats
killed 5 weeks after the last DMH injection were: one crypt
per focus, 157.8+22.5; two crypts per focus, 126.0+18.0;
three crypts per focus, 58.3 +7.1; four crypts per focus,
28.8+5.4; five crypts per focus, 8.0+2.0; six crypts per focus,
1.0+0.4. Very few ACF larger than six crypts per focus were
seen. The mean total number of ACF per rat in groups of
rats killed at either 1 or 5 weeks after the last of eight weekly
injections of DMH was subjected to ANOVA. The mean
number of ACF per rat at 1 week after the last DMH
injection was significantly less than at 5 weeks after the last
DMH injection (228+39 vs 380+55, P < 0.05, n = 4 rats
per group). This significant increase in ACF between 1 and 5
weeks after the last DMH injection indicates that the total
number of ACF continued to increase in the absence of
additional carcinogen adminstration.
Distribution ofdifferent sized ACF along the length of the
colon
The average numbers of ACF of different sizes found in each
centimetre along the length of the colon (expressed per
1.25 cm2 of pinned-out colonic luminal surface area) were
scored in rats (four per group) killed either 1 week or 5 weeks
after the last of the eight weekly injections of DMH. The
results are illustrated in Figure 2a and b. Most of the ACF of
all size classes occurred in the distal half of the colon with a
unimodal peak of the ACF occurring between the sites ofthe
two most distal ALN. Few ACF occurred in the proximal
half of the colon and no ACF occurred in the most proximal
quarter of the colon.
Correlation analyses between (1) the distribution ofACF at I
or at 5 weeks after the last DMH injection: (2) the
distribution of tumours at 24 weeks after the last DMH
injection; and (3) the distribution ofpre-existing ALN along
the length of the colon
Figure 2c illustrates the distribution of adenomas and the
distribution of AC along the length of the colon scored 24
weeks after the last of the eight weekly injections of DMH
(n = 335 tumours in 402 rats.) Histological examination
identified only 4.8% of all colon tumours as adenomas.
There were three peaks in the distribution of AC along the
length of the colon. The numerical distribution of adenomas
along the length of the colon was not the same as the
distribution of AC; specfically, 81% (13/16) of the adenomas
were located between the sites of the distal two ALN but
most of the ACs were located within the confines of the three
sites of ALNs.
Table I presents the data on the distribution of 2640 ACF
(from eight rats) and 335 tumours (from 402 rats) along the
length of the colon of the DMH-treated rats. Linear
regression analyses were performed on the data in Table I
to determine if the numerical distribution of ACF (scored at
1 week or 5 weeks after the last DMH injection) correlated
significantly with the numerical distribution of either
adenomas or of ACs along the length of the colon (scored
at 24 weeks after the last injection of DMH). The results of
linear regression analyses indicated that the number of ACF
along the length of the colon (counted at either 1 week or S
weeks after the last DMH injection) did not correlate
significantly (P<0.05) with the number of adenomas or
with the number of AC found along the length of the colon
at 24 weeks after the last DMH injection.
To assess further the relationships between the distribu-
tions of ACF, ACs (of two morphological types, either
polypoid or sessile) and ALNs along the length of the colon
of DMH-treated Sprague-Dawley rats, the ACF data
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Figure 2 Distribution of ACF (classified as to the number of
crypts involved, i.e. 1, 2, 3, etc. as indicated) ofadenomas, ofACs
and ALNs along the length ofthe colon ofrats killed (a) 1, (b) 5 or
(c) 24 weeks after the last eight weekly injections of DMH. The
numbers of different-sized ACF were scored in two groups with
four rats in each group; a total of2640 ACF were counted. The per
cent ofthe total number of adenomas and ofAC in DMH-treated
rats is plotted as a function of distance from the anus to ileum
(data from Table I). All grossly visible tumours were classified by
histology as an adenoma or as an AC. The tumour data were
compiled from 335 tumours found in 402 Sprague-Dawley rats.
The location of ALNs in the rat colon (determined from 20 non-
DMH-treated rats) was measured as the distance from the anus to
the distal end and to the proximal end of each ALN. The solid
portion of the bar spans the distance between the mean of the
distal end and the mean of the proximal end of each ALN, the
open portion of the bar indicates one standard deviation (s.d.)
from that mean. The mean+1 s.d. ofthe distal and proximal ends
of each ALN (in per cent of total distance from the anus to the
ileum) were as follows: distal ALN, 16.5+1.29 to 21.9+2.2;
middle ALN, 51.7+5.7 to 56.0+5.9; and proximal ALN 86.5 +
5.7 to 90.1 +6.3. No solitary lymphoid nodules were seen outside
the locations indicated by the bars for ALN. This illustrates
congruence in the occurrence of DMH-induced ACs and the
locations of ALN in the rat, but lack of congruence in the
distribution of ACF and the distribution of ACs.
I
I
I
I
I
1%1%
10Lymph nodules, aberrant crypts and colon cancer
IL Cameron et al
896
collected from the experiments reported herein (collected at 1
week and at 5 weeks after eight subcutaneous injections of
DMH) were correlated with published data which provided
the distribution of tumours and ALNs (Nauss et al., 1984)
collected 4-14 months after a series of intragastric doses of
DMH. The results of linear regression analyses between these
data sets (as listed in the different columns of Table II)
indicate: (1) that the distribution of ALN found at the time
of sacrifice of the DMH-treated rats in the previous study
(Nauss et al., 1984) was significantly correlated (P<0.05)
with the distribution of the more numerous sessile ACs but
was not significantly correlated (P>0.05) with the distribu-
tion of the less numerous polypoid ACs; and (2) that the
number of ACF (found at either 1 week or 5 weeks after the
last exposure to DMH) did not correlate (P>0.05) with the
distributions of either sessile or polypoid ACs along the
length of the colon. The finding from the regression analyses
between the two sets of experimental data must be tempered
by the fact that the data of Nauss et al. (1984) were obtained
on rats given DMH via intragastric gavage whereas the ACF
data are from rats given DMH via subcutaneous injections.
This and other differences between experiments makes the
analyses less stringent than the analyses of data presented in
Table I (data collected using the same protocol).
Discussion
A main finding of this study is that the distribution of ACF
along the length of the colon of carcinogen (DMH)-treated
rats is not the same as the distribution of carcinogen-induced
ACs which form in rats; thus, neither the number nor the size
of ACF could be expected to directly predict the occurrence
ofAC. The lack ofcorrelation between ACF and AC and the
significant correlation between ALN and AC indicates that it
is the enhancement of carcinogenesis due to the presence of
ALN, not the numbers or distribution pattern ofACF, which
is the main determinant of the distribution of ACs in the
carcinogen-treated rats. The main reasons why the numbers
and/or sizes of ACF have not been shown to predict the
incidence of colonic AC reliably may be that the promotional
effect of the ALNs is quite specific to the formation of
endophytic ACs and/or that the promotional effect of the
ALNs is localised to a relatively small proportion of the total
luminal surface area of the colon of rats where ALNs occur.
In this regard, it has been reported that about 70% of rat
colonic ACs are endophytic or sessile ACs (Nauss et al.,
1984; Martin et al., 1986; Hardman and Cameron, 1994) that
are found in association with the small areas of ALNs.
It is worth noting that visible ALNs were observed in the
Table I Distribution of aberrant crypt foci (ACF), adenomas and adenocarcinomas along the length of the colon of Sprague-Dawley rats
sacrificed at 1 week, at 5 weeks or at 24 weeks after the last eight weekly injections of dimethylhydrazinea
-2 % of total tumours
Average total number of ACF 1.25 cm per rat Adenomas Adenocarcinomas
Percentage distance n=1120, 4 rats n= 1520, 4 rats n= 16, 402 rats n=319, 402 rats
from anus to ileum (I week) (5 weeks) (24 weeks) (24 weeks)
15 22.0 42.5 0.6 22.9
20 29.5 40.8 - -
25 37.5 57.0 0.0 25.4
30 42.0 77.5 - -
35 49.0 58.3 1.5 4.5
40 38.0 48.5 - -
45 29.0 31.8 2.1 16.7
50 20.5 15.0 - -
55 8.0 6.3 0.3 7.5
60 4.5 2.8 - -
65 0.5 1.0 0.0 1.5
70 0.0 0.8 - -
75 0.0 0.0 0.0 3.3
80 0.0 0.0 - -
85 0.0 0.0 0.3 10.2
90 0.0 0.0 - -
95 0.0 0.0 0.0 3.3
aThe results oflinear regression analyses between the values listed in the different columns are presented in the text.
Table II Distribution of aberrant crypt foci (data from the study presented in this report) of adenocarcinomas (divided into polypoid and
sessile types) and ofaggregates oflymphoid nodules (the adenocarcinoma and ALN data are from experiment no.3 in the report ofNauss et al.
1984) along the length of the colon of Sprague-Dawley rats (sacrificed at times given in parenthesis) after the last of a series of five or eight
weekly exposures (either intragastric or subcutaneous injections) to dimethylhydrazinea
Percentage Aberrant crypt foci Adenocarcinomas Aggregates of
distance number 1.25cm-2 Polypoid Sessile lymphoid nodules
from anus n=4 rats n =4 rats n= 159 rats n= 159 rats n=159 rats
to ileumb (I week) (5 weeks) (4-14 months) (4-14 months) (4-14 months)
6.3 4.4 8.5 2 1 2
18.8 31.0 47.2 4 11 80
31.3 42.2 64.0 4 2 18
43.8 27.4 28.5 13 8 44
56.3 5.2 3.8 13 24 51
68.8 0 0.3 2 0 15
81.3 0 0 6 40 67
93.8 0 0 3 14 26
100.0 0 0 1 4 0
aThe results oflinear regression analyses between the values listed in the different columns are presented in the text. bData ofNauss et al. (1984)
werecollected from 3cm length segments. The mean (in per cent ofthe totaldistance from the anus to the iluem) ofeach segmentis reported in this
table.Lymph nodules, aberrant crypts and colon cancer
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proximal quarter of the colon in the majority of the rats, but
that none of the 2640 ACF were found in this proximal
quarter of the colon at either 1 or 5 weeks after the last
DMH injection. As the distribution of ACF was not scored
in the proximal portion of the colon at 24 weeks after the last
DMH injection, it cannot be claimed with certainty that no
ACF ever arise in this region of the colon. However, if an
ACF arises in this segment of the colon it must be considered
an extremely rare event. Thus, it seems highly unlikely that
ACs which do form in this proximal quarter of the colon
could have arisen via an ACF precursor pathway. The likely
explanation for AC genesis in this proximal segment of the
colon is via the de novo pathway of AC formation.
If one assumes, for the sake of discussion, that ACF are
the sole precursor lesions to ACs, then one can calculate the
expected conversion of ACF to ACs. For example, based on
the data in Table I, the average number of ACF per rat at 5
weeks was 380; this compares with an average of 0.79 ACs
per rat at 24 weeks after the last DMH injection. Thus, only
a small percentage (0.2%) of the ACF present at 5 weeks
could have evolved into ACs present at 24 weeks. Similar
calculations done at about 35% ofthe distance from the anus
to the ileum results in an even lower percentage of possible
conversions of ACF to ACs (0.06%) in the area between the
two distal ALNs. This latter estimate of possible conversion
of putative premalignant foci to malignant foci in an area of
the colon without putative promotion effects from the
lymphatic nodules compares with an estimate of 0.02% for
conversion of carcinogen-induced premalignant aberrant liver
foci to malignant tumours in the rat liver (Williams and
Watanbe, 1978). Based on these calculations, it may be
concluded that progression from a carcinogen-altered foci to
a malignant tumour is rare both in the liver and in the colon
of rats. However, the calculated conversion of ACF to ACs
(based on the data in Table I) is 4- to 5-fold higher in the
sites of the two distal ALNs in the rat colon than in the area
between the two distal ALN sites. Thus, ALNs are either
promotional to the rare conversion of ACF to become ACs
and/or are promotional to the de novo formation of ACs.
These two possibilities are not mutually exclusive in the distal
colon, but either possibility indicates a promotional role for
ALNs in colon carcinogenesis. Calculation of the potential
ACF to AC conversion percentages in the proximal quarter
of the colon was not possible as no ACF could be found in
the proximal quarter of the colon.
The above findings are not intended to convey to the
reader that measurement of the numbers, size and distribu-
tion of ACF in rats is of little or no value as a biomarker of
colon carcinogenesis. The number ofACF found in the colon
is undoubtedly an indicator of exposure to the known colon
carcinogens so far tested (McLellan and Bird, 1988; Tudek et
al., 1989), and in this regard ACF can be said to reflect risk
of colon cancer. But because neither the number nor the size
of ACF has proved a significant predictor of AC formation
along the length of the colon in the rat model system (this
report) or in the mouse (Carter et al., 1994), the use of the
total numbers or size of ACF in the colon of rats is not
necessarily a valid indicator of the risk of malignant colon
cancer. Indeed, there are now several reports from
independent studies which fail to confirm numbers of ACF
as a reliable indicator of cancer risk throughout the colon of
rats (Hardman et al., 1991; Magnuson and Bird, 1993;
Magnuson et al., 1993; Caderni et al., 1995; Thorup et al.,
1994).
In conclusion, the results from the present and from past
reports (Nauss et al., 1984; Shimamoto and Vollmer, 1987;
Martin et al., 1986; Hardman and Cameron, 1994; Carter et
al., 1994; Shamsuddin and Hogan, 1984) indicate a strong
promotional role for lymphoid nodules in colon carcinogen-
esis. That ACs can arise along a pathway that does not pass
through an ACF stage seems highly likely in the proximal
quarter of the colon of the rat (data in this report). It also
seems that there is no direct proof that any aberrant crypt
foci progress to become malignant cancer, nor is there direct
proof to the contrary. The question remains: do ACF
represent true premalignant lesions which on rare occasion
progress via a multistep process to become ACs or do ACF
and colon AC represent end points of two parallel but
independent pathways resulting as a consequence of a
common colon cancer initiation (Thorup et al., 1994; Jen et
al., 1994; Smith et al., 1994; Yamashita et al., 1995; Pretlow,
1995)? Serial observations using endoscopic procedures on
humans and on animal models followed by terminal histology
may eventually provide direct evidence on the fate of ACE.
Regardless of the outcome, the fact remains that the numbers
and the multiplicity (size) of ACF are currently being used as
biomarkers of colon cancer risk (Lam and Zhang, 1991;
Periera and Khoury, 1991; O'Riordan et al., 1991; Wargovich
et al., 1992; Rao et al., 1993; Zhang et al., 1992; Deschner et
al., 1990; Pereira et al., 1994) but interpretation of the results
of intervention studies that use ACF as biomarkers of
efficacy of intervention must take into account the
questionable value of ACF numbers and sizes as valid
predictors of colon cancer risk.
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